Clinical Trial Update: GB001 in Adult Subjects With Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial update for GB001 in adults with moderate to severe asthma has completed, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GB001

Snippet

Sponsor: GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2021-08-23